Although both pharmacological approaches target GLP-1, important differences exist concerning the mode of administration (subcutaneous injection versus oral ingestion), the efficacy (better with GLP-1 agonists), the effects on body weight and systolic blood pressure (diminution with agonists versus neutrality with gliptins), the tolerance profile (nausea and possibly vomiting with agonists) and the cost (higher with GLP-1 receptor agonists)
Legal Considerations The legal framework surrounding compounded GLP-1 medications touches on federal law, state law, FDA regulations, and ongoing court cases
Cloudy means contamination
Hence, a more thorough pharmacological characterization is necessary for each developed compound
Lower your legs slowly without letting them touch the ground, and repeat
I figure another 30 days and Ill be where I wanna be